Biotech entity
pharma is the sole category represented across all 1 tracked stories. 4D Medical is most often covered alongside Anteris Technologies, which appears in 1 of these 1 story. 4D Medical appears in 1 tracked Biotech story from February 25, 2026.
Last mentioned: Feb 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. 4D Medical is most often covered alongside Anteris Technologies, which appears in 1 of these 1 story. 4D Medical appears in 1 tracked Biotech story from February 25, 2026. The tracked stories average 5 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering 4D Medical. Shared-story counts are live from our verified record — not editorial picks.
The global biotech sector has diverged into a 'two-speed' market, where innovative drug discovery and device firms are outperforming established healthcare heavyweights. Despite regulatory uncertainty under the Trump administration and a 25% decline in the ASX 200 healthcare sector, the Nasdaq Biotech Index has surged 30%, supported by record-breaking capital raises.
4D Medical is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
